Core Insights - The company has developed new products in electronic accelerator, new materials, and optoelectronic chip businesses, indicating a strong focus on innovation and market expansion [1] Electronic Accelerator Business - The company has successfully developed the first domestic S-band 10MeV/32kW high-power industrial irradiation electronic accelerator for disinfection and sterilization, which offers higher power and processing efficiency compared to the traditional 20kW accelerator, meeting high-dose disinfection needs for high-capacity clients [1] New Materials Business - The company has independently developed and produced irradiation cross-linked ethylene-tetrafluoroethylene copolymer (XETFE), which has broad application prospects in aerospace and low-altitude economy, achieving domestic substitution for imported materials [1] Optoelectronic Chip Business - The company’s high-performance silicon photomultiplier packaging production line is set to be operational in the first half of 2025, showcasing advancements in the optoelectronic chip sector [1] Medical Health Business - The company is increasing R&D investment in medical health, focusing on developing a miniaturized proton therapy system, with technical breakthroughs and design plans already completed [1] - In the isotope sector, the company is conducting research on the production processes of copper-64 and zirconium-89 using accelerators, with plans for future industrialization based on market demand [1]